Brain Canada Brain Canada
FR Donate

Drug repurposing in medulloblastoma using integrated functional genomic, epigenomic, and transcriptomic approaches

Principal Investigator:
  • Deena Gendoo, The Hospital For Sick Children

Project Overview

The project conducted by Dr. Gendoo is focused upon identifying potential therapeutic targets against Medulloblastoma (MB) subtypes. Identification of subtype-specific therapies is contingent upon: 1) proper classification of samples into MB subtypes; and 2) proper understanding of the pharmacological space and the interaction between drugs and potential targets.